Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment
- PMID: 15655427
- DOI: 10.1097/00005650-200502000-00007
Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment
Abstract
Background: Recent studies suggest differences in quality and timeliness of care received may be major contributing sources to the racial disparity in breast cancer detection and related outcomes.
Methods: Female patients with breast cancer diagnosed during 1985-1993 (n=400) and followed through June 20, 2001, were included in this retrospective cohort study. Three white patients were selected randomly and matched to each black patient by year of diagnosis. Method and timing of diagnosis and timing of treatment were abstracted from medical records. Initial staging and subsequent breast cancer recurrence and vital status were obtained from the Hospital and Connecticut State Tumor Registry.
Results: Black women were more likely than white women to be diagnosed after a patient-noted abnormality. Black women were less likely than white women to have completed a diagnostic evaluation within 30 days after a patient-noted abnormality (P <0.01) or after having an abnormality noted on screening mammogram (P=0.0001) and were less likely to have initiated treatment within 30 days of diagnosis (P=0.0001). Women diagnosed after a patient-noted abnormality were more likely to have subsequent breast cancer recurrence and/or death due to breast cancer compared with women diagnosed after a screening mammogram (56% versus 24%, respectively, P <0.05).
Conclusions: Racial differences were identified at each step in the evaluation and treatment clinical pathway, including method of detection, timing from first symptoms of cancer to pathologic diagnosis, and timing from diagnosis to initiation of treatment. The findings highlight the need to provide equal opportunity for timely medical care and treatment.
Similar articles
-
Vital signs: racial disparities in breast cancer severity--United States, 2005-2009.MMWR Morb Mortal Wkly Rep. 2012 Nov 16;61(45):922-6. MMWR Morb Mortal Wkly Rep. 2012. PMID: 23151952
-
Factors associated with delays to diagnosis and treatment of breast cancer in women in a Louisiana urban safety net hospital.Women Health. 2010 Dec;50(8):705-18. doi: 10.1080/03630242.2010.530928. Women Health. 2010. PMID: 21170814
-
Social determinants of Black-White disparities in breast cancer mortality: a review.Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2913-23. doi: 10.1158/1055-9965.EPI-07-0633. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990731 Review.
-
Differences in breast cancer prognosis among African-American and Caucasian women.CA Cancer J Clin. 2000 Jan-Feb;50(1):50-64. doi: 10.3322/canjclin.50.1.50. CA Cancer J Clin. 2000. PMID: 10735015 Review.
-
Breast carcinoma tumor characteristics in black and white women.Cancer. 1998 Dec 15;83(12):2509-15. doi: 10.1002/(sici)1097-0142(19981215)83:12<2509::aid-cncr15>3.0.co;2-v. Cancer. 1998. PMID: 9874456
Cited by
-
Development and Evaluation of Messages for Reducing Overscreening of Breast Cancer in Older Women.Med Care. 2024 May 1;62(5):296-304. doi: 10.1097/MLR.0000000000001993. Epub 2024 Mar 12. Med Care. 2024. PMID: 38498875 Clinical Trial.
-
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: a Pilot Study.J Racial Ethn Health Disparities. 2023 Dec 11. doi: 10.1007/s40615-023-01865-2. Online ahead of print. J Racial Ethn Health Disparities. 2023. PMID: 38082068
-
Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.Breast Cancer Res Treat. 2024 Feb;203(3):575-586. doi: 10.1007/s10549-023-07134-4. Epub 2023 Nov 6. Breast Cancer Res Treat. 2024. PMID: 37930491 Free PMC article.
-
Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis.Cancer Causes Control. 2024 Feb;35(2):253-263. doi: 10.1007/s10552-023-01785-w. Epub 2023 Sep 13. Cancer Causes Control. 2024. PMID: 37702967
-
The Devastating Impact of the COVID-19 Pandemic on Breast Cancer Care Among Medically Underserved Populations at Two New York City Public Hospitals.Ann Surg Open. 2020 Oct 19;1(2):e018. doi: 10.1097/AS9.0000000000000018. eCollection 2020 Dec. Ann Surg Open. 2020. PMID: 37637441 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical